Related Experiment Video
Updated: Jun 18, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Post-mastectomy radiotherapy
1Department of Radiation Oncology and Molecular Radiation Services, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA. zellari@jhmi.edu
Clinical Advances in Hematology & Oncology : H&O
|November 26, 2009
Summary
Post-mastectomy radiation therapy (PMRT) remains controversial despite decades of research. This review examines the history and ongoing debates surrounding PMRT, including its use in specific breast cancer cases and associated toxicities.
Area of Science:
- Oncology
- Radiotherapy
- Breast Cancer Research
Background:
- Three pivotal studies published between 1997-1999 reignited the debate on post-mastectomy radiation therapy (PMRT).
- Despite extensive follow-up and re-analyses, the findings from these trials continue to be a subject of vigorous discussion in breast cancer care.
- This review commemorates the 10th anniversary of the Danish Breast Cancer Cooperative Group Post-Mastectomy trial 82c publication.
Purpose of the Study:
- To provide a historical overview of the controversies surrounding PMRT.
- To discuss related issues such as PMRT with neo-adjuvant chemotherapy, positive margins, T3N0 tumors, and internal mammary lymph node irradiation.
- To familiarize readers with debated aspects of PMRT and prepare them for informed discussion.
Main Methods:
- Literature review and historical analysis of key studies and controversies in PMRT.
- Discussion of specific clinical scenarios and related treatment controversies.
- Examination of the toxicities associated with PMRT.
Main Results:
- The 1997-1999 studies on PMRT generated persistent debate, impacting clinical practice and research directions.
- Ongoing controversies include the role of PMRT in specific patient subgroups and the inclusion of internal mammary lymph node irradiation.
- Toxicities associated with PMRT are a significant consideration in treatment decisions.
Conclusions:
- The debate on PMRT is multifaceted, involving efficacy, patient selection, and treatment-related toxicities.
- Understanding the historical context and current controversies is crucial for oncologists and researchers.
- Further research and discussion are needed to optimize the use of PMRT in breast cancer management.
